
Oncology drugs have especially fallen victim to chronic shortages, consequently affecting the availability of substitute agents.

Oncology drugs have especially fallen victim to chronic shortages, consequently affecting the availability of substitute agents.

Why is this man gaining weight, instead of losing it, while taking a natural supplement?

A phase 2 clinical trial demonstrated that a 2-week course of teplizumab was able to delay the onset of clinical type 1 diabetes by 3 years compared with patients taking a placebo.

The researchers identified 87 articles using the PubMed and PsycINFO databases and the 2017 American Academy of Neurology (AAN) criteria for therapeutic trials.

Vitamin C and zinc are among the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.

Tips for pharmacy professionals on how to best counsel patients who have concerns regarding their brain health.

Researchers found that replacing 30 minutes of inactivity with exercise significantly reduces the risk of cancer-related death.

Tumor- induced osteomalacia is a rare disease that is characterized by tumors causing soft and weakened bones.

Today, we’re celebrating Larisa Janoczkin, PharmD, a pharmacist with CVS is Howell, New Jersey.

The authors posited that teriflunomide could prevent an excessive immune response while still maintaining enough defense against the virus.

The intent of the study was to bring awareness to the medical and nonmedical financial hardships of cancer and how they can impact the use of preventive services, since there is little research available to evaluate this topic, according to the study authors.

The study results show improvements at each stage in the HPV vaccination series.

According to a new study by West Health and Gallup, 88% of US adults support the federal government directly negotiating the price of a COVID-19 treatment with a drug manufacturer upon its availability due to concerns regarding raised drug prices.

In the United States, 3.5 million people have been diagnosed with schizophrenia and it is a leading cause of disability.

What year was the second dose of the measles, mumps, and rubella (MMR) vaccine recommended?

Top news of the week from Pharmacy Times®.

The FDA has approved tazemetostat for the treatment of 2 different follicular lymphoma (FL) indications.

Guselkumab is a monoclonal antibody that selectively binds to the p19 subunit of IL-23 and inhibits its interaction with the IL-23.

Student pharmacists across the country have had to adjust their expectations of what P4 year will look like.

Experts discuss insights from NHA's 2019 Industry Outlook research from employers of pharmacy technicians to better understanding their needs and the value of certification for this role.

Today, we’re celebrating Morgan Adams, PharmD, a pharmacist with CVS in Connecticut.

Using artificial intelligence (AI) and automated monitoring, researchers and physicians at Oregon Health & Science University (OHSU) have designed a method to help people with type 1 diabetes better manage their glucose levels.

Research shows that the over-prescribing of opioids for short term pain management is a widespread issue in the United States.

SE requires prompt intervention to terminate seizure activity to prevent neuronal damage and complications.

Antibodies isolatied from plasma donated from recovered COVID-19 patients fights the virus that causes COVID-19.

Statins have been and continue to be the first-choice therapy options for patients, but the addition of Nexletol adds a different new dimension to managing this disease.

Pharmacy managers will need to employ effective decision-making that will include evaluating vendors for post-purchase support, and discern the right time to purchase technology.

Giant Food has announced that all vaccinations recommended by the ACIP are once again available at its 153 in-store pharmacies across Virginia, Maryland, Delaware, and the District of Columbia.

individuals with four or more depressive symptoms had a 20% increase in cardiovascular events and death.

Galcanezumab-gnlm (Emgality, Lilly) has received FDA-approval for the preventive treatment of migraine in adults and for the treatment of episodic cluster headache in adults.